HKSecWiki新股资讯 2022年09月22日
01:00 AM EDT, 09/22/2022 (MT Newswires) -- Betters Medical Investment Holdings (HKG:6678) kicked off its initial public offering in Hong Kong on Thursday, undeterred by the market volatility amid concerns of a recession following a series of interest rate hikes by the US Federal Reserve.
美国东部时间2022年09月22日凌晨01：00(MT Newswres)-Betters Medical Investment Holdings(HKG：6678)周四在香港启动首次公开募股(IPO)，在美国联邦储备委员会(Federal Reserve)一系列加息后对经济衰退的担忧中，市场波动并未吓倒该公司。
The microwave ablation medical device maker will issue 248 million shares at HK$1.40 to HK$1.72 each, a listing that could raise as much as HK$426.6 million ($54.3 million) if priced at the upper end of the marketed range.
这家微波消融医疗设备制造商将以每股1.40港元至1.72港元的价格发行2.48亿股，如果定价在市场区间的上限，此次发行可能筹资至多4.266亿港元(合5430万美元)。
Of the total shares on offer, 24.8 million are earmarked for Hong Kong investors. An overallotment option of up to 37.2 million shares can be exercised if there is strong demand for the deal.
在此次发行的全部股票中，有2480万股是为香港投资者指定的。如果交易需求强劲，可以行使最多3720万股的超额配售选择权。
Betters Med counts Bank of China (HKG:3988, SHA:601988) and IPE (HKG:0929) among its pre-IPO investors.
Betters Med的首次公开招股前投资者包括中国银行(HKG：3988，SHA：601988)和IPE(HKG：0929)。
The Guangzhou-headquartered company expects to determine the IPO price on Sept. 27 and disclose the allocations on Oct. 3. It intends to start trading on the Hong Kong bourse on Oct. 5.
这家总部位于广州的公司预计将于9月9日确定IPO价格。27，并于10月3日披露配置情况。该公司计划于10月5日在香港交易所开始交易。
Betters Medical will use the deal proceeds to broaden its product portfolio, upgrade medical licenses, enlarge the research and development team, widen the indication coverage of its existing devices, finance R&D studies and acquisitions, as well as expand its presence in overseas markets.
Betters Medical将利用这笔交易所得扩大其产品组合，升级医疗执照，扩大研发团队，扩大其现有设备的适应症覆盖范围，为研发研究和收购提供资金，以及扩大其在海外市场的存在。
BOCI Asia, Zhongtai International, China Galaxy International, Cinda International, Huatai Financial, Eddid Securities, China Everbright Securities, Guosen Securities, China Industrial Securities, Valuable Capital and ZMF Asset Management are the joint lead managers and book-runners of the IPO.
中银亚洲、中泰国际、中国银河国际、信达国际、华泰证券金融、爱德华德证券、中国光大证券、国信证券、中国兴业证券、宝贵资本和ZMF Asset Management为是次IPO的联席牵头经办人兼账簿管理人。
本页的译文内容由软件翻译。富途将竭力但却不能保证翻译内容之准确和可靠，亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
Was this helpful?
0 / 0
本文链接： https://www.hksecwiki.com/news/p19764291/
由HKSecWiki香港券商百科整理发布，香港证券开户请访问hksecwiki.com